Landon Capital

Landon capital

Capital Market News, Capital Markets Now

MRSN

27.43 USD

+ 209.24%
NVVE

0.4758 USD

+ 204.61%
CLNNW

0.008 USD

+ 90.48%
NVVEW

0.0282 USD

+ 56.67%
APLMW

0.0209 USD

+ 54.81%
DRCT

0.2854 USD

+ 44.07%
NETDW

0.054 USD

+ 40.26%
IDN

6.18 USD

+ 37.95%
TNMG

0.411 USD

+ 37.18%
LEXXW

0.0651 USD

+ 37.05%
DFDVW

4.47 USD

+ 35.87%
YDESW

0.99 USD

+ 35.62%
FLYT

15.53 USD

+ 33.94%
OXBRW

0.28 USD

+ 33.14%
NVNIW

0.089 USD

+ 32.84%
SGBX

3.16 USD

+ 32.22%
BTBDW

0.1916 USD

+ 31.59%
CYCU

4.18 USD

+ 31.03%
BBLGW

20.27 USD

+ 29.94%
MAGH

2.48 USD

+ 27.84%

Top Gainer

Latest News

Let’s make a deal, Merck (NYSE: MRK) to acquire Cidara for $9.2 billion  Merck (NYSE: MRK) announced it will acquire Cidara Therapeutics (CDTX) for $221.50 per share in cash, valuing the transaction at approximately $9.2 billion. The acquisition centers on Cidara’s lead candidate CD388, an investigational antiviral agent currently in Phase 3 trials for influenza prevention. CD388 is designed to …